Pear Therapeutics Announces th - GuruFocus.com
GuruFocus Article or News written by Business Wire and the topic is about:
Source: gurufocus.com
Page 4 - Software Precertification Pilot Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Software Precertification Pilot Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Software Precertification Pilot Program Today - Breaking & Trending Today
Pear Therapeutics and Crossroads Treatment Centers to Provide More Patients Access to Prescription Digital Therapeutics as Standard of Care for the Treatment of Substance Use Disorders
BOSTON--(BUSINESS WIRE)--Dec 15, 2021--
Source: wsiltv.com
Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company
BOSTON--(BUSINESS WIRE)--Dec 3, 2021--
Source: midfloridanewspapers.com
Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders
Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders By Staff 2 seconds ago Prescryptive Health, a health intelligence platform focused on improving the prescription drug market and the pharmacy experience, teams with Pear to make innovative prescription digital therapeutics (PDTs) accessible to its members in recovery. Prescryptive Health will offer and administer Pear’s reSET® and reSET-O® through its digital platform as a covered standard pharmacy benefit...
Source: digitalmedianet.com
Pear Therapeutics Announces Second Closing of Series D Financing
Company adds a leading national Integrated Delivery Network (IDN) as a strategic investor. The financing supports Pear’s continued efforts to expand patient access for its portfolio of Prescription Digital Therapeutics (PDTs), including reSET®, reSET-O® and Somryst® treating addiction and insomnia conditions, respectively. BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc., (“Pear” or the “Company”) today announced the second closing of its Series D financing. The second closing included a leading national Integrated Delivery Network (IDN) as a new strategic inves...
Source: digitalmedianet.com